General Healthy(605186)2024-10-11 09:07Group 1: Company Overview and Strategy - The company focuses on providing intelligent management solutions for the pharmaceutical industry, driven by technological innovation to meet market demands [1] - It aims to strengthen its research and development capabilities and actively seeks overseas collaboration opportunities to compensate for domestic demand shortages [1][2] Group 2: Financial Performance - In the first half of 2024, the company reported a revenue of 145.5194 million yuan, a decrease of 17.73% compared to the same period last year [2] - The net profit attributable to shareholders was 29.5444 million yuan, reflecting a decline of 47.06% year-on-year [2] Group 3: Technological Innovation and Market Adaptation - The company has a well-established R&D system with a team that has nearly 20 years of experience in the industry, demonstrating strong capabilities in technological innovation and product development [2] - In response to the slowdown in domestic market demand for automated pharmacy upgrades, the company is adjusting its strategy to expand into overseas markets with customized R&D efforts [2]